Will Johnson & Johnson (NYSE:JNJ) beat analyts view?

Rodiano Bonacci
Aprile 17, 2018

Hefty Wealth Partners now owns 1,121 shares of the company's stock valued at $132,000 after buying an additional 951 shares in the last quarter. JNJ has 4.74M shares volume. Microsoft Corporation (NASDAQ:MSFT) has risen 37.43% since April 17, 2017 and is uptrending. Johnson & Johnson comprises 0.3% of New Capital Management LP's investment portfolio, making the stock its 25th largest position. $353.47B is the MC of Johnsn&Johnsn.

The stock decreased 1.53% or $2.02 during the last trading session, reaching $129.74. About 3.02 million shares traded.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, January 23rd. The stock underperformed the S&P 500 by 10.43%.

During Q4 2017 the big money sentiment increased to 0.87. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold Johnson & Johnson shares while 884 reduced holdings. Itau Unibanco Holding S.A. bought a new position in Johnson & Johnson during the third quarter valued at about $104,000. Northern Cap Mngmt Limited Liability Com has 34,642 shs. Steinberg Glob Asset, Florida-based fund reported 22,935 shs. Beach Investment Management LLC. lifted its holdings in Johnson & Johnson by 1,256.6% during the 2nd quarter. Jpmorgan Chase holds 209,425 shares. Ipswich Investment Mngmt has invested 0.22% in General Mills, Inc. Moreover, Gamble Jones Investment Counsel has 2.65% invested in Johnson & Johnson (NYSE:JNJ). (NYSE:GIS). Ballentine Partners Limited Liability, Massachusetts-based fund reported 7,222 shares. Df Dent reported 0.33% in Johnson & Johnson (NYSE:JNJ). First State Bank Sioux Falls reported 3.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Keybank National Association Oh accumulated 76,257 shares. Farmers Savings Bank reported 61,034 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 50% are positive. $136.72's average target is 3.76% above currents $131.76 stock price. On Monday, October 23 the rating was maintained by Citigroup with "Buy". As per Wednesday, October 18, the company rating was maintained by RBC Capital Markets. The rating was maintained by Cowen & Co on Tuesday, June 13 with "Buy". Morgan Stanley has "Equal-Weight" rating and $143 target. On Thursday, October 19 the stock has "Buy" rating by Credit Suisse. The stock has "Neutral" rating by JP Morgan on Tuesday, January 2. On Friday, January 12 the stock has "Buy" rating by Wells Fargo. It also increased its holding in Hcp Inc. General Electric Co (NYSE:GE) was raised too. Shares for $20.17M were sold by Stoffels Paulus. Lincoln stated it has 0.26% in Johnson & Johnson (NYSE:JNJ). $64.18's average target is 18.68% above currents $54.08 stock price. The company was upgraded on Monday, August 24 by Piper Jaffray. As per Tuesday, December 1, the company rating was upgraded by Barclays Capital. Vetr lowered shares of Johnson & Johnson from a "strong-buy" rating to a "hold" rating and set a $124.55 price objective for the company.in a research note on Monday, March 26th. Wells Fargo has "Buy" rating and $160.0 target. As per Wednesday, June 21, the company rating was maintained by UBS. Wunderlich maintained the stock with "Hold" rating in Wednesday, July 20 report. (NYSE:NYCB) on Thursday, January 26 with "Underperform" rating. Stifel Nicolaus maintained it with "Hold" rating and $145 target in Wednesday, January 24 report.

Since December 12, 2017, it had 1 insider buy, and 1 insider sale for $85,985 activity.

Johnson & Johnson's (JNJ) is expected to announce its next earnings on 4/17/2018 8:30:00 AM.

Johnson & Johnson reported higher-than-expected sales in its latest quarter and boosted its sales outlook for the year despite ongoing pricing pressures for its prescription drugs and medical devices. JNJ's profit will be $5.39B for 16.25 P/E if the $2.01 EPS becomes a reality. EPS growth in past five years was 7.10% while EPS growth in next five years is projected to arrive at 7.91%. Its down 0.09, from 1.03 in 2017Q3. 134 funds opened positions while 676 raised stakes. California-based Private Ocean Lc has invested 0.01% in Johnson & Johnson (NYSE:JNJ). Tdam Usa Inc has invested 0.09% of its portfolio in General Mills, Inc. Account Management Ltd reported 1.03% stake. Great West Life Assurance Company Can owns 526,552 shares. Homrich & Berg has invested 0.04% in Bristol-Myers Squibb Company (NYSE:BMY).

J&J said it would boost capital expenditure by 15 percent in the United States, bringing the total to $30 billion over the next four years as it reinvests a windfall from USA tax reforms. (NYSE:GIS) or 3,750 shares. Harding Loevner Ltd Partnership holds 0% or 800 shs in its capital. Marshwinds Advisory holds 1.2% or 18,586 shares. Shelton Mngmt stated it has 248,816 shares. Ims Mgmt invested in 0.77% or 20,178 shares. They are valued at $439.20 million in 2017Q4.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE